- Home
- BNGO vs HOTH Comparison
BNGO vs HOTH Comparison
Compare BNGO & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNGO
- HOTH
- Stock Information
- Founded
- BNGO 2003
- HOTH 2017
- Country
- BNGO United States
- HOTH United States
- Employees
- BNGO N/A
- HOTH N/A
- Industry
- BNGO Biotechnology: Laboratory Analytical Instruments
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- BNGO Industrials
- HOTH Health Care
- Exchange
- BNGO Nasdaq
- HOTH Nasdaq
- Market Cap
- BNGO 24.3M
- HOTH 20.9M
- IPO Year
- BNGO 2018
- HOTH 2019
- Fundamental
- Price
- BNGO $1.95
- HOTH $1.53
- Analyst Decision
- BNGO Buy
- HOTH Strong Buy
- Analyst Count
- BNGO 4
- HOTH 3
- Target Price
- BNGO $7.67
- HOTH $4.00
- AVG Volume (30 Days)
- BNGO 1.6M
- HOTH 1.2M
- Earning Date
- BNGO 11-12-2025
- HOTH 11-11-2025
- Dividend Yield
- BNGO N/A
- HOTH N/A
- EPS Growth
- BNGO N/A
- HOTH N/A
- EPS
- BNGO N/A
- HOTH N/A
- Revenue
- BNGO $27,426,000.00
- HOTH N/A
- Revenue This Year
- BNGO N/A
- HOTH N/A
- Revenue Next Year
- BNGO $24.54
- HOTH N/A
- P/E Ratio
- BNGO N/A
- HOTH N/A
- Revenue Growth
- BNGO N/A
- HOTH N/A
- 52 Week Low
- BNGO $1.50
- HOTH $0.65
- 52 Week High
- BNGO $25.65
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- BNGO 39.67
- HOTH 45.26
- Support Level
- BNGO $1.63
- HOTH $1.46
- Resistance Level
- BNGO $2.15
- HOTH $1.72
- Average True Range (ATR)
- BNGO 0.12
- HOTH 0.13
- MACD
- BNGO 0.08
- HOTH -0.03
- Stochastic Oscillator
- BNGO 60.64
- HOTH 9.52
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).